Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Richert-Boe

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Blood|August 1, 1978
32P and acute leukemia: development of leukemia in a patient with hemoglobin YakimaG C Bagby, K Richert-Boe, R D Koler
Blood|August 1, 1979
Prednisone-responsive aplastic anemia: a mechanism of glucocorticoid actionG C Bagby, S H Goodnight, W M Mooney, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1996
Tumor board formats: "fascinating case" versus "working conference"J T Vetto, K Richert-Boe, M Desler, et al.
Cancer|April 1, 1981
Therapy-related preleukemic syndromeR L Anderson, G C Bagby, K Richert-Boe, et al.
Public Health Genomics|May 5, 2011
HER2 evaluation and its impact on breast cancer treatment decisionsK A B Goddard, S Weinmann, K Richert-Boe, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Blood|August 1, 1978
32P and acute leukemia: development of leukemia in a patient with hemoglobin YakimaG C Bagby, K Richert-Boe, R D Koler
Blood|August 1, 1979
Prednisone-responsive aplastic anemia: a mechanism of glucocorticoid actionG C Bagby, S H Goodnight, W M Mooney, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1996
Tumor board formats: "fascinating case" versus "working conference"J T Vetto, K Richert-Boe, M Desler, et al.
Cancer|April 1, 1981
Therapy-related preleukemic syndromeR L Anderson, G C Bagby, K Richert-Boe, et al.
Public Health Genomics|May 5, 2011
HER2 evaluation and its impact on breast cancer treatment decisionsK A B Goddard, S Weinmann, K Richert-Boe, et al.
Pageof 1